We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
42 hedge funds and large institutions have $58.4M invested in CTI BioPharma Corp. (DE) Common Stock in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
5% more funds holding
Funds holding: 40 → 42 (+2)
4% less capital invested
Capital invested by funds: $61M → $58.4M (-$2.54M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
42
Holders Change
+2
Holders Change %
+5%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
11
Reduced
5
Closed
7
Calls
$209K
Puts
–
Net Calls
+$209K
Net Calls Change
-$88K
Top Buyers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.78M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.08M |
| 3 |
Renaissance Technologies
New York
|
+$916K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$684K |
| 5 |
JP Morgan Chase
New York
|
+$285K |
